| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 3.539 | 0 | - | 7.494 | 27.147 | 31.254 | 64.656 | 2.162 | 77.500 | 498.655 |
| Total Income - EUR | 3.539 | 0 | - | 7.494 | 27.157 | 31.254 | 65.667 | 2.163 | 83.385 | 499.737 |
| Total Expenses - EUR | 2.356 | 1 | - | 458 | 841 | 1.681 | 14.919 | 40.830 | 114.943 | 344.486 |
| Gross Profit/Loss - EUR | 1.184 | -1 | - | 7.036 | 26.316 | 29.573 | 50.748 | -38.667 | -31.558 | 155.251 |
| Net Profit/Loss - EUR | 1.078 | -1 | - | 6.812 | 25.501 | 29.110 | 49.035 | -38.732 | -32.391 | 142.080 |
| Employees | 1 | 0 | - | 0 | 0 | 1 | 1 | 1 | 0 | 3 |
Check the financial reports for the company - Pro Receptura Med S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 0 | 0 | - | 0 | 0 | 0 | 1.247 | 29.252 | 4.083 | 125.394 |
| Current Assets | 2.079 | 2.057 | - | 5.151 | 30.847 | 60.241 | 49.098 | 9.567 | 20.326 | 178.894 |
| Inventories | 0 | 0 | - | 0 | 0 | 0 | 0 | 602 | 2.738 | 188.773 |
| Receivables | 192 | 190 | - | 0 | 1.012 | 5.168 | 4 | 6.939 | 10.989 | -16.706 |
| Cash | 1.887 | 1.866 | - | 5.151 | 29.836 | 55.073 | 49.094 | 2.026 | 6.598 | 6.827 |
| Shareholders Funds | -1.973 | -1.954 | - | 4.926 | 30.332 | 58.866 | 50.051 | -16.273 | -48.615 | 94.096 |
| Social Capital | 45 | 45 | - | 43 | 42 | 41 | 40 | 41 | 40 | 402 |
| Debts | 4.052 | 4.011 | - | 225 | 516 | 1.375 | 293 | 55.371 | 73.050 | 210.191 |
| Income in Advance | 0 | 0 | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4646 - 4646" | |||||||||
| CAEN Financial Year |
4646
|
|||||||||
Comments - Pro Receptura Med S.r.l.